Abstract

PurposeThe Dementia-Related Quality of Life (DEMQOL) measure and the DEMQOL-Utility Score (DEMQOL-U) are validated tools for measuring quality of life (QOL) in people with dementia. What score changes translate to a clinically significant impact on patients’ lives was unknown. This study establishes the minimal important differences (MID) for these two instruments.MethodsAnchor-based and distribution-based methods were used to estimate the MID scores from patients enrolled in a randomised controlled trial. For the anchor-based method, the global QOL (Q29) item from the DEMQOL was chosen as the anchor for DEMQOL and both Q29 and EQ-5D for DEMQOL-U. A one category difference in Q29, and a 0.07 point difference in EQ-5D score, were used to classify improvement and deterioration, and the MID scores were calculated for each category. These results were compared with scores obtained by the distribution-based methods.ResultsA total of 490 people with dementia had baseline DEMQOL data, of these 386 had 8-month data, and 344 had 12-month DEMQOL data. The absolute change in DEMQOL for a combined 1-point increase or decrease in the Q29 anchor was 5.2 at 8 months and 6.0 at 12 months. For the DEMQOL-U, the average absolute change at 8 and 12 months was 0.032 and 0.046 for the Q29 anchor and 0.020 and 0.024 for EQ-5D anchor.ConclusionWe present MID scores for the DEMQOL and DEMQOL-U instruments obtained from a large cohort of patients with dementia. An anchored-based estimate of the MID for the DEMQOL is around 5 to 6 points; and 0.02 to 0.05 points for the DEMQOL-U. The results of this study can guide clinicians and researchers in the interpretation of these instruments comparisons between groups or within groups of people with dementia.Trial Registration Number and date of registration:ISRCTN17993825 on 11th October 2016.

Highlights

  • Dementia is an umbrella term for a variety of diseases and conditions affecting the brain distinguished by a decline in memory, language, problem-solving and other thinking skills that affect a person’s ability to perform everyday activities

  • We looked at the Dementia-Related Quality of Life (DEMQOL)-Utility score which ranges from 0.243 to 0.986 and is

  • A total of 490 participants were recruited to the Journeying through Dementia (JtD) study and had available baseline DEMQOL data, of these 386 had 8-month data, and 344 had both baseline and 12-month DEMQOL data

Read more

Summary

Introduction

Dementia is an umbrella term for a variety of diseases and conditions affecting the brain distinguished by a decline in memory, language, problem-solving and other thinking skills that affect a person’s ability to perform everyday activities. There are a number of sub-types of dementia, but the five most common are Alzheimer’s disease, vascular dementia, dementia with Lewy bodies, frontotemporal dementia and mixed dementia. Alzheimer’s is the most common cause of dementia [1]. Around 50 million people have dementia, and there are up to 10 million new cases every year [3]. Projections show that there will be 82 million people with dementia in 2030 and 152 million in 2050 [3]. Alzheimer’s Research UK reports that there are over 850,000 people currently living with dementia in the UK [4]. It is estimated that the number of people with dementia in the UK will rise to over one million by 2021 [1]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call